{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:18:39Z","timestamp":1790605119149,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01569-3","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T04:31:03Z","timestamp":1740803463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Amiodarone-induced ocular and extra-ocular toxicity: a retrospective cohort study"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-4876","authenticated-orcid":false,"given":"Rosanna","family":"Dammacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6545-2273","authenticated-orcid":false,"given":"Silvana","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3262-8401","authenticated-orcid":false,"given":"Giuseppina","family":"Cardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8313-4159","authenticated-orcid":false,"given":"Giovanni","family":"Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4567-8216","authenticated-orcid":false,"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-5471","authenticated-orcid":false,"given":"Franco","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"1569_CR1","unstructured":"Florek JB, Lucas A, Girzadas D. Amiodarone. 2023 Jun 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan\u2013. PMID: 29489285."},{"key":"1569_CR2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-98-5-577","volume":"98","author":"K Nademanee","year":"1983","unstructured":"Nademanee K, Singh BN, Hendrickson J, et al. Amiodarone in refractory life-threatening ventricular arrhythmias. Ann Intern Med. 1983;98:577\u201384.","journal-title":"Ann Intern Med"},{"issue":"4 Pt 2","key":"1569_CR3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0002-8703(83)90006-6","volume":"106","author":"DW Holt","year":"1983","unstructured":"Holt DW, Tucker GT, Jackson PR, Storey GC. Amiodarone pharmacokinetics. Am Heart J. 1983;106(4 Pt 2):840\u20137.","journal-title":"Am Heart J"},{"issue":"12","key":"1569_CR4","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.3390\/diagnostics12123217","volume":"12","author":"CE Budin","year":"2022","unstructured":"Budin CE, Cocuz IG, Sab\u0103u AH, et al. Pulmonary fibrosis related to amiodarone-is it a standard pathophysiological pattern? A case-based literature review. Diagnostics. 2022;12(12):3217.","journal-title":"Diagnostics"},{"issue":"3","key":"1569_CR5","first-page":"e36818","volume":"15","author":"MU Scaramozzino Sr","year":"2023","unstructured":"Scaramozzino MU Sr, Sapone G, Plastina UR, Nucara M. Amiodarone-induced lung toxicity: a case initially not correctly framed. Cureus. 2023;15(3):e36818.","journal-title":"Cureus"},{"issue":"3","key":"1569_CR6","first-page":"125","volume":"28","author":"Y Saito","year":"2023","unstructured":"Saito Y, Watanabe T, Oyama C, et al. Amiodarone-induced syndrome of inappropriate antidiuresis with hepatic transaminitis. J Cardiol Cases. 2023;28(3):125\u20137.","journal-title":"J Cardiol Cases"},{"issue":"3","key":"1569_CR7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0735-1097(97)00220-9","volume":"30","author":"VR Vorperian","year":"1997","unstructured":"Vorperian VR, Havighurst TC, Miller S, January CT. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol. 1997;30(3):791\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1569_CR8","doi-asserted-by":"crossref","first-page":"104835","DOI":"10.1016\/j.dib.2019.104835","volume":"28","author":"MK Moroi","year":"2019","unstructured":"Moroi MK, Ruzieh M, Aboujamous NM, et al. Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials. Data Brief. 2019;28:104835.","journal-title":"Data Brief"},{"key":"1569_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.amjcard.2022.11.045","volume":"189","author":"A Kaur","year":"2023","unstructured":"Kaur A, Mehta D, Mahmood K, Tamis-Holland J. A rare case of blue-gray discoloration induced by low-dose amiodarone. Am J Cardiol. 2023;189:119\u201320.","journal-title":"Am J Cardiol"},{"key":"1569_CR10","doi-asserted-by":"crossref","first-page":"104521","DOI":"10.1016\/j.phrs.2019.104521","volume":"151","author":"N Mujovi\u0107","year":"2020","unstructured":"Mujovi\u0107 N, Dobrev D, Marinkovi\u0107 M, Russo V, Potpara TS. The role of amiodarone in contemporary management of complex cardiac arrhythmias. Pharmacol Res. 2020;151:104521.","journal-title":"Pharmacol Res"},{"issue":"2","key":"1569_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/europace\/euac217","volume":"25","author":"SA Ali","year":"2023","unstructured":"Ali SA, Ersb\u0142ll M, Vinding NE, et al. Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study. Europace. 2023;25(2):291\u20139.","journal-title":"Europace"},{"issue":"9","key":"1569_CR12","first-page":"91","volume":"9","author":"AJ Sweidan","year":"2016","unstructured":"Sweidan AJ, Singh NK, Dang N, Lam V, Datta J. Amiodarone-induced pulmonary toxicity\u2014a frequently missed complication. Clin Med Insights Case Rep. 2016;9(9):91\u20134.","journal-title":"Clin Med Insights Case Rep"},{"issue":"2","key":"1569_CR13","first-page":"233","volume":"78","author":"A Stratton","year":"2015","unstructured":"Stratton A, Fenderson J, Kenny P, Helman DL. Severe acute hepatitis following intravenous amiodarone: a case report and review of the literature. Acta Gastroenterol Belg. 2015;78(2):233\u20139.","journal-title":"Acta Gastroenterol Belg"},{"key":"1569_CR14","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.12659\/MSM.890881","volume":"20","author":"K Jaworski","year":"2014","unstructured":"Jaworski K, Walecka I, Rudnicka L, Gnatowski M, Kosior DA. Cutaneous adverse reactions of amiodarone. Med Sci Monit. 2014;20:2369\u201372.","journal-title":"Med Sci Monit"},{"issue":"10","key":"1569_CR15","first-page":"e10913","volume":"12","author":"A Kohli","year":"2020","unstructured":"Kohli A, Sharma AV. Amiodarone-induced neutropenia: an uncommon side effect of a common drug. Cureus. 2020;12(10):e10913.","journal-title":"Cureus"},{"issue":"3","key":"1569_CR16","first-page":"13671","volume":"13","author":"H Chhatrala","year":"2021","unstructured":"Chhatrala H, Ghetiya S, Chahin M, Zuberi L, Quan W. Amiodarone-Induced Immune Thrombocytopenia: A Rare Hematologic Side Effect of a Common Cardiac Drug. Cureus. 2021;13(3):13671.","journal-title":"Cureus."},{"issue":"5","key":"1569_CR17","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1111\/j.1468-1331.2012.03678.x","volume":"19","author":"EP Flanagan","year":"2012","unstructured":"Flanagan EP, Harper CM, St Louis EK, Silber MH, Josephs KA. Amiodarone-associated neuromyopathy: a report of four cases. Eur J Neurol. 2012;19(5):e50\u20131.","journal-title":"Eur J Neurol"},{"issue":"4","key":"1569_CR18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2515\/therapie:2007057","volume":"62","author":"I Salouage","year":"2007","unstructured":"Salouage I, Klouz A, Trabelsi S, et al. Neuro-psychiatric disorders induced by Amiodarone high levels (Cordarone). Therapie. 2007;62(4):357\u20139.","journal-title":"Therapie"},{"issue":"5","key":"1569_CR19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3904\/kjim.2014.29.5.588","volume":"29","author":"HL Kim","year":"2014","unstructured":"Kim HL, Seo JB, Chung WY, Kim SH, Kim MA, Zo JH. The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice. Korean J Intern Med. 2014;29(5):588\u201396.","journal-title":"Korean J Intern Med"},{"issue":"5","key":"1569_CR20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.amjmed.2011.09.020","volume":"125","author":"RS Passman","year":"2012","unstructured":"Passman RS, Bennett CL, Purpura JM, et al. Amiodarone-associated optic neuropathy: a critical review. Am J Med. 2012;125(5):447\u201353.","journal-title":"Am J Med"},{"issue":"1","key":"1569_CR21","doi-asserted-by":"crossref","first-page":"e000943","DOI":"10.1136\/bmjophth-2021-000943","volume":"7","author":"JY Sahyoun","year":"2022","unstructured":"Sahyoun JY, Sabeti S, Robert MC. Drug-induced corneal deposits: an up-to-date review. BMJ Open Ophthalmol. 2022;7(1):e000943.","journal-title":"BMJ Open Ophthalmol"},{"issue":"1","key":"1569_CR22","doi-asserted-by":"crossref","first-page":"e002555","DOI":"10.1136\/openhrt-2023-002555","volume":"11","author":"A Fritz Hansson","year":"2024","unstructured":"Fritz Hansson A, Modica A, Renlund H, Christersson C, Held C, Batra G. Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study. Open Heart. 2024;11(1):e002555.","journal-title":"Open Heart"},{"issue":"2","key":"1569_CR23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","volume":"9","author":"R Latini","year":"1984","unstructured":"Latini R, Tognoni G, Kates RE. Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet. 1984;9(2):136\u201356.","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"1569_CR24","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/IAE.0000000000001019","volume":"36","author":"A Maleki","year":"2016","unstructured":"Maleki A, Cao JH, Silpa-Archa S, Foster CS. Visual outcome and poor prognostic factors in isolated idiopathic retinal vasculitis. Retina. 2016;36(10):1979\u201385.","journal-title":"Retina"},{"issue":"4","key":"1569_CR25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archopht.1982.01030030603011","volume":"100","author":"LJ Kaplan","year":"1982","unstructured":"Kaplan LJ, Cappaert WE. Amiodarone keratopathy. Correlation to dosage and duration. Arch Ophthalmol. 1982;100(4):601\u20132.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"1569_CR26","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0161-6420(84)34165-3","volume":"91","author":"RG Orlando","year":"1984","unstructured":"Orlando RG, Dangel ME, Schaal SF. Clinical experience and grading of amiodarone keratopathy. Ophthalmology. 1984;91(10):1184\u20137.","journal-title":"Ophthalmology"},{"issue":"4","key":"1569_CR27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archinte.1987.00370040117020","volume":"147","author":"I Weinberger","year":"1987","unstructured":"Weinberger I, Rotenberg Z, Fuchs J, Ben-Sasson E, Agmon J. Amiodarone-induced thrombocytopenia. Arch Intern Med. 1987;147(4):735\u20136.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1569_CR28","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.4081\/hr.2010.e6","volume":"2","author":"AJ Erie","year":"2010","unstructured":"Erie AJ, McClure RF, Wolanskyj AP. Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia. Hematol Rep. 2010;2(1):e6.","journal-title":"Hematol Rep"},{"issue":"2","key":"1569_CR29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/thy.2018.0274","volume":"29","author":"M Gershinsky","year":"2019","unstructured":"Gershinsky M, Saliba W, Lavi I, Shapira C, Gronich N. Increased risk of antithyroid drug agranulocytosis associated with amiodarone-induced thyrotoxicosis: a populationbased cohort study. Thyroid. 2019;29(2):193\u2013201.","journal-title":"Thyroid"},{"issue":"9","key":"1569_CR30","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.hrthm.2007.07.020","volume":"4","author":"N Goldschlager","year":"2007","unstructured":"Goldschlager N, Epstein AE, Naccarelli GV, et al. Practice guidelines sub-committee, North American Society of pacing and electrophysiology (HRS). A practical guide for clinicians who treat patients with amiodarone. Heart Rhythm. 2007;4(9):1250\u20139.","journal-title":"Heart Rhythm"},{"issue":"1","key":"1569_CR31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jep.12619","volume":"23","author":"CJ Huang","year":"2017","unstructured":"Huang CJ, Tseng CL, Chu CH, Huang DF, Huang CC, Lin LY. Adherence to guidelines in monitoring amiodarone-induced thyroid dysfunction. J Eval Clin Pract. 2017;23(1):108\u201313.","journal-title":"J Eval Clin Pract"},{"key":"1569_CR32","first-page":"233339281984463","volume":"6","author":"O Lavon","year":"2019","unstructured":"Lavon O, Goldman R. Adherence to monitoring guidelines of amiodarone adverse reactions. Health Serv Res Manag Epidemiol. 2019;6:2333392819844635.","journal-title":"Health Serv Res Manag Epidemiol"},{"issue":"4","key":"1569_CR33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0039-6257(97)00118-5","volume":"42","author":"M Mantyjarvi","year":"1998","unstructured":"Mantyjarvi M, Tuppurainen K, Heimo IK. Ocular side effects of amiodarone. Surv Ophthalmol. 1998;42(4):360\u20136.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"1569_CR34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.survophthal.2016.11.008","volume":"62","author":"MB Raizman","year":"2017","unstructured":"Raizman MB, Hamrah P, Holland EJ, et al. Drug-induced corneal epithelial changes. Surv Ophthalmol. 2017;62(3):286\u2013301.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"1569_CR35","first-page":"96","volume":"17","author":"E Chew","year":"1982","unstructured":"Chew E, Ghosh M, McCulloch C. Amiodarone-induced cornea verticillata. Can J Ophthalmol. 1982;17(3):96\u20139.","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"1569_CR36","first-page":"178","volume":"19","author":"M Ghosh","year":"1984","unstructured":"Ghosh M, McCulloch C. Amiodarone-induced ultrastructural changes in human eyes. Can J Ophthalmol. 1984;19(4):178\u201386.","journal-title":"Can J Ophthalmol"},{"issue":"7","key":"1569_CR37","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/OPX.0000000000001534","volume":"97","author":"M Alshehri","year":"2020","unstructured":"Alshehri M, Joury A. Ocular adverse effects of amiodarone: a systematic review of case reports. Optom Vis Sci. 2020;97(7):536\u201342.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"1569_CR38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/1319-4534.310400","volume":"34","author":"F Al Adel","year":"2021","unstructured":"Al Adel F, Shoughy SS, Tabbara KF. Hydroxychloroquine dosing and toxicity: a real-world experience in Saudi Arabia of 63 patients. Saudi J Ophthalmol. 2021;34(3):151\u20135.","journal-title":"Saudi J Ophthalmol"},{"issue":"6","key":"1569_CR39","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/jpm13060904","volume":"13","author":"G Gambini","year":"2023","unstructured":"Gambini G, Scartozzi L, Giannuzzi F, et al. Ophthalmic manifestations in fabry disease: updated review. J Pers Med. 2023;13(6):904.","journal-title":"J Pers Med."},{"issue":"2","key":"1569_CR40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archopht.1981.03930010259007","volume":"99","author":"DJ D\u2019Amico","year":"1981","unstructured":"D\u2019Amico DJ, Kenyon KR, Ruskin JN. Amiodarone keratopathy: drug-induced lipid storage disease. Arch Ophthalmol. 1981;99(2):257\u201361.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1569_CR41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/08820530390895163","volume":"18","author":"D Chen","year":"2003","unstructured":"Chen D, Hedges TR. Amiodarone optic neuropathy\u2013review. Semin Ophthalmol. 2003;18(4):169\u201373.","journal-title":"Semin Ophthalmol"},{"issue":"9","key":"1569_CR42","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/biom12091298","volume":"12","author":"R Mitchell","year":"2022","unstructured":"Mitchell R, Chacko J. Clinical and mechanistic review of amiodarone-associated optic neuropathy. Biomolecules. 2022;12(9):1298.","journal-title":"Biomolecules"},{"issue":"5","key":"1569_CR43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0002-9394(99)00016-1","volume":"127","author":"DC Macaluso","year":"1999","unstructured":"Macaluso DC, Shults WT, Fraunfelder FT. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol. 1999;127(5):610\u20132.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"1569_CR44","first-page":"1477","volume":"96","author":"LN Johnson","year":"2004","unstructured":"Johnson LN, Krohel GB, Thomas ER. The clinical spectrum of amiodarone-associated optic neuropathy. J Natl Med Assoc. 2004;96(11):1477\u201391.","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"1569_CR45","first-page":"240","volume":"22","author":"E Martino","year":"2001","unstructured":"Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev. 2001;22(2):240\u201354.","journal-title":"Endocr Rev"},{"issue":"4","key":"1569_CR46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0885066613503278","volume":"30","author":"S Danzi","year":"2015","unstructured":"Danzi S, Klein I. Amiodarone-induced thyroid dysfunction. J Intensive Care Med. 2015;30(4):179\u201385.","journal-title":"J Intensive Care Med"},{"issue":"2","key":"1569_CR47","first-page":"327","volume":"61","author":"F Medi\u0107","year":"2022","unstructured":"Medi\u0107 F, Bakula M, Alfirevi\u0107 M, Bakula M, Muci\u0107 K, Mari\u0107 N. Amiodarone and thyroid dysfunction. Acta Clin Croat. 2022;61(2):327\u201341.","journal-title":"Acta Clin Croat"},{"issue":"2","key":"1569_CR48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40618-023-02168-3","volume":"47","author":"D Cappellani","year":"2024","unstructured":"Cappellani D, Bartalena L, Bogazzi F. Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis. J Endocrinol Invest. 2024;47(2):275\u201383.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1569_CR49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.1840090504","volume":"9","author":"JH Lewis","year":"1989","unstructured":"Lewis JH, Ranard RC, Caruso A, et al. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology. 1989;9(5):679\u201385.","journal-title":"Hepatology"},{"key":"1569_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-023-08251-2","author":"A Pop","year":"2024","unstructured":"Pop A, Halegoua-DeMarzio D, Barnhart H, et al. Amiodarone and dronedarone causes liver injury with distinctly different clinical presentations. Dig Dis Sci. 2024. https:\/\/doi.org\/10.1007\/s10620-023-08251-2.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"1569_CR51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/157016108784912019","volume":"6","author":"M Babatin","year":"2008","unstructured":"Babatin M, Lee SS, Pollak PT. Amiodarone hepatotoxicity. Curr Vasc Pharmacol. 2008;6(3):228\u201336.","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"1569_CR52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0046-8177(90)90076-H","volume":"21","author":"JH Lewis","year":"1990","unstructured":"Lewis JH, Mullick F, Ishak KG, et al. Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol. 1990;21(1):59\u201367.","journal-title":"Hum Pathol"},{"issue":"9","key":"1569_CR53","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s003300000809","volume":"11","author":"H Vernhet","year":"2001","unstructured":"Vernhet H, Bousquet C, Durand G, Giron J, Senac JP. Reversible amiodarone-induced lung disease: HRCT findings. Eur Radiol. 2001;11(9):1697\u2013703.","journal-title":"Eur Radiol"},{"key":"1569_CR54","doi-asserted-by":"crossref","first-page":"bcr2017219373","DOI":"10.1136\/bcr-2017-219373","volume":"2017","author":"DC Voruganti","year":"2017","unstructured":"Voruganti DC, Cadaret L. Amiodarone-induced interstitial pneumonitis. BMJ Case Rep. 2017;2017:bcr2017219373.","journal-title":"BMJ Case Rep"},{"issue":"8","key":"1569_CR55","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1021\/acs.chemrestox.1c00127","volume":"34","author":"R Kato","year":"2021","unstructured":"Kato R, Ijiri Y, Hayashi T. Amiodarone, unlike dronedarone, activates inflammasomes via its reactive metabolites: implications for amiodarone adverse reactions. Chem Res Toxicol. 2021;34(8):1860\u20135.","journal-title":"Chem Res Toxicol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01569-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:44:58Z","timestamp":1764917098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01569-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1569"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01569-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The corresponding author is Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were carried out in compliance with the ethical standards of the University of Bari and in accordance with the tenets of the 1964 Declaration of Helsinki and its later amendments. The ethical approval for the study was given by the ethics committee of the University of Bari Medical School. The need for written informed consent was waived by the ethics committee because of the retrospective nature of the study. No animal experiments were included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent statement"}}],"article-number":"68"}}